A cheap steroid called dexamethasone, which is used to reduce inflammation in diseases such as arthritis, has become the first drug shown to be able to save the lives of COVID-19 patients in what scientists called a “major breakthrough.” Early results from a trial, led by a team from Oxford University, were announced in the U.K. on Tuesday, showing that dexamethasone reduced COVID-19 death rates by around a third among the country’s most severely ill infected patients.
Health
Coronavirus: Early study hails steroid as ‘breakthrough’ COVID-19 drug
More Videos
-
Ozempic maker bringing weight-loss drug Wegovy to Canada
-
Health Matters: Newfoundland and Labrador work to hire, retain nurses through incentives
-
Toxic metals in vapes linked with major health problems in youth, study finds
-
Ozempic-makers’ weight-loss drug, Wegovy, coming soon to Canada
-
Weight-loss drug Wegovy available in Canada starting May 6
-
Health Matters: Caregiver report highlights need for help
You are viewing an Accelerated Mobile Webpage.
View Original Article